Whorl Pharmaceuticals Private Limited
About Whorl Pharmaceuticals Private Limited
Data last updated:
Whorl Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 27 December 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2018PTC343568. Its GSTIN is 07AACCW3412B1ZW (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mamta Kumari and Ranjan Kumar Mishra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A 2/306 G/F Khno. – 837 Ishwar Colony Aya Nagar Extn. Phase – 5 New Delhi, Delhi, India – 110047.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.39 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net profit of ₹920 (net margin 0.2%) and EBITDA of ₹920 (EBITDA margin 0.2%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 57% over five years.
Company details
Contact details
Whorl Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA 2/306 G/F Khno. – 837 Ishwar Colony Aya Nagar Extn. Phase – 5 New Delhi, Delhi, India – 110047
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Whorl Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Whorl Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Whorl Pharmaceuticals Private Limited, buy the company report.
Financials of Whorl Pharmaceuticals Private Limited
FY 2025 filings availableWhorl Pharmaceuticals Private Limited reported revenue of ₹5.39 Lakh (up 36% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 36% growth in the latest year. EBITDA rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹920 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹920 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Whorl Pharmaceuticals Private Limited, buy the company report.
Board of directors of Whorl Pharmaceuticals Private Limited
Whorl Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mamta Kumari | Director | 27 Dec 2018 | 7 Years 10 Months | Current |
| Ranjan Kumar Mishra | Director | 27 Dec 2018 | 7 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Whorl Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Whorl Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Whorl Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCW3412B1ZW | Delhi | Active | 02 Feb 2020 |
To see the full GST registrations and return filing status of Whorl Pharmaceuticals Private Limited, buy the company report.
Recent activity
Whorl Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Mamta Kumari was appointed as Director on 27 Dec 2018.
Frequently asked questions
Whorl Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 27 December 2018 (8+ years old) and is registered under CIN U24290DL2018PTC343568.
Whorl Pharmaceuticals has 2 current directors:
- Mamta Kumari - Director
- Ranjan Kumar Mishra - Director
The latest financial statements of Whorl Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Whorl Pharmaceuticals is 07AACCW3412B1ZW, registered in Delhi.
The CIN (Corporate Identification Number) of Whorl Pharmaceuticals is U24290DL2018PTC343568. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Whorl Pharmaceuticals was incorporated on 27 December 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
Mamta Kumari was appointed as Director on 27 Dec 2018. Ranjan Kumar Mishra was appointed as Director on 27 Dec 2018.
The registered office of Whorl Pharmaceuticals is at A 2306 GF Khno. – 837 Ishwar Colony Aya Nagar Extn. Phase – 5 New Delhi, Delhi, India – 110047.
Whorl Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Whorl Pharmaceuticals can be reached at its registered office: A 2306 GF Khno. – 837 Ishwar Colony Aya Nagar Extn. Phase – 5 New Delhi, Delhi, India – 110047.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
